This topic contains a solution. Click here to go to the answer

Author Question: Which of the following refers to a risk, stemming from environmental factors, that is closely ... (Read 66 times)

tuffie

  • Hero Member
  • *****
  • Posts: 534
Which of the following refers to a risk, stemming from environmental factors, that is closely associated with global sourcing?
 
  A) weak intellectual property laws
  B) overreliance on suppliers
  C) high energy costs
  D) rapid turnover of skilled employees

Question 2

International portfolio investment refers to a firm's direct control of foreign operations and is an equity-based method of foreign market entry.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

strudel15

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

C

Answer to Question 2

FALSE




tuffie

  • Member
  • Posts: 534
Reply 2 on: Jul 7, 2018
Gracias!


softEldritch

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Excellent

 

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library